Functional analysis of recombinant pancreatic secretory trypsin inhibitor protein with amino-acid substitution

Journal of Gastroenterology

Volumn 37, Issue 11, 2002, Pages 928-934

  Kuwata, Kinuko ^a   Hirota, Masahiko ^a   Shimizu, Hiroyuki ^b   Nakae, Masanori ^b   Nishihara, Shoji ^b   Takimoto, Akio ^b   Mitsushima, Kenji ^b   Kikuchi, Norihisa ^b   Endo, Kazuaki ^b   Inoue, Masayasu ^c   Ogawa, Michio ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic pancreatitis; Familial pancreatitis; PSTI; Recombinant protein; Trypsin

Indexed keywords

APROTININ; ASPARAGINE; CALCIUM; RECOMBINANT PROTEIN; SERINE; TRYPSIN;

ACIDITY; ALKALINITY; AMINO ACID SUBSTITUTION; ARTICLE; BIOCHEMISTRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXON; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; HYPOTHESIS; INHIBITION KINETICS; PANCREATITIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PROCESSING; WILD TYPE;

AMINO ACID SUBSTITUTION; ANIMALS; CARRIER PROTEINS; CATTLE; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GROWTH SUBSTANCES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTAGENESIS, SITE-DIRECTED; MUTATION; PANCREATITIS; RECOMBINANT PROTEINS; TIME FACTORS; TRYPSIN INHIBITOR, KAZAL PANCREATIC;

EID: 0036857490     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350200156     Document Type: Article

References (18)

1. Bartelt DC, Shapanka R, Greene LJ. The primary structure of the human pancreatic secretory trypsin inhibitor. Amino acid sequence of the reduced S-aminoethylated protein. Acta Biochem Biophys 1977;179:189-99.
2. Horii A, Kobayashi T, Tomita N, Yamamoto T, Fukushige S, Murotsu T, et al. Primary structure of human secretory trypsin inhibitor (PSTI) gene. Biochem Biophys Res Commun 1987;149: 635-41.
3. Kuwata K, Hirota M, Sugita H, Kai M, Hayashi M, Nakamura M, et al. Genetic mutations in exons 3 and 4 of the pancreatic secretory trypsin inhibitor in patients with pancreatitis. J Gastroenterol 2001;36:612-8.
4. Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, Landt O. Mutations in the gene encoding the serine protease inhibitor, Kazal type I, are associated with chronic pancreatitis. Nature Genet 2000;25:213-6.
5. Chen JM, Mercier B, Audrezet MP, Ferec C. Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis. J Med Genet 2000;37:67-9.
6. Pfützer RH, Barmada MM, Brunskill AP, Finch R, Hart PS, Neoptolemos J, et al. SPINK/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000;119:615-23.
7. Kaneko K, Nagasaki Y, Furukawa T, Mizutamari H, Sato A, Masumura A, et al. Analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene mutations in Japanese patients with chronic pancreatitis. J Hum Genet 2001;46:293-7.
8. Chen JM, Mercier B, Audrezet MP, Raguenes O, Quere I, Ferec C. Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis. Gastroenterology 2001; 120:1061-3.
9. Kikuchi N, Nagata K, Shin M, Mitsushima K, Teraoka H, Yoshida N. Site-directed mutagenesis of human pancreatic secretory trypsin inhibitor. J Biochem 1989;106:1059-63.
10. Taylor JW, Schmidt W, Cosstick R, Okruszek A, Eckstein F. The use of phosphorothioate-modified DNA in restriction enzyme reactions to prepare nicked DNA. Nucleic Acids Res 1985;13: 8749-64.
11. Taylor JW, Ott J, Eckstein F. The rapid generation of digonucleotide-directed mutations at high frequency using phosphorothioate-modified DNA. Nucleic Acids Res 1985;13: 8765-85.
12. Kikuchi N, Nagata K, Yoshida N, Ogawa M. The multiplicity of human pancreatic secretory trypsin inhibitor. J Biochem 1985;98: 687-94.
13. Halangk W, Lerch MM, Brabdt-Nedelev B, Roth W, Ruthenbuerger M, Reinheckel T, et al. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest 2000;106:773-81.
14. Green NM, Work E. Pancreatic trypsin inhbitor. II. Reaction with trypsin. Biochem J 1953;54:347-52.
15. Saluja AK, Donovan EA, Yamanaka K, Yamatuchi Y, Hofbauer B, Steer ML. Cerulein-induced in vitro activation of trypsinogen in rat pancreatic acini is mediated by cathepsin B. Gastroenterology 1997;113:304-10.
16. Rossi L, Pfützer RH, Parvin S, Ali L, Sattar S, Kahn AKA, Gyr N, Whitcomb DC. SPINK1/PSTI mutations are associated with tropical pancreatitis in Bangladesh. Pancreatology 2001;1:242-5.
17. Chu CS, Trapnell BC, Curristin S, Cutting GR, Crystal RG. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nature Genet 1993;3: 151-6.
18. Tarlow JL, Blakemore AIF, Lennard A. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993;91:403-4.